Profile change history

What changed for Sermorelin?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Sermorelin identity.

6Total events
6Record additions
0Version changes
6Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 6 connected records →

Showing the latest 6 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

Federal Register notice 2013-04827

The Federal Register published notice 2013-04827, attributed to FDA and its parent HHS department, on 2013-03-04. Its official title is “Determination That GEREF (Sermorelin Acetate) Injection, 0.5 Milligrams Base/Vial and 1.0 Milligrams Base/Vial, and GEREF (Sermorelin Acetate) Injection, 0.05 Milligrams Base/Amp, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Sermorelin.

PeptideScanner change date
November 16, 2026
Cited source date
March 4, 2013
Evidence lane
Regulatory
Record added

Federal Register notice E9-11628

The Federal Register published notice E9-11628, attributed to FDA and its parent HHS department, on 2009-05-19. Its official title is “Novartis Pharmaceuticals Corp. et al.; Withdrawal of Approval of 92 New Drug Applications and 49 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin and Sermorelin.

PeptideScanner change date
November 16, 2026
Cited source date
May 19, 2009
Evidence lane
Regulatory
Record added

Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.

PubMed lists PMID 18031173 in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy as Journal Article, with publication-date metadata of 1999-08 (month precision). PeptideScanner associated the retained record with the identity slug sermorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 25, 2018
Evidence lane
Literature metadata
Record added

Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?

PubMed lists PMID 18046908 in Clinical interventions in aging as Editorial, with publication-date metadata of 2006 (year precision). PeptideScanner associated the retained record with the identity slug sermorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 20, 2021
Evidence lane
Literature metadata